نتائج البحث

Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes

• Authors : The Leona M. and Harry B. Helmsley Charitable Trust; Jeremy Pettus, MD, Assistant Professor of Medicine

• Source: Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1

تفاصيل العنوان

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (OPTI-2)

• Source: A Phase 2b Randomized, Double-blind Trial Comparing HDV-Insulin Lispro Versus Insulin

تفاصيل العنوان

A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

• Source: Effectiveness of a Basal Rate Reduction With LyumjevTM Versus Humalog® on the Protection From Exercise-Induced Hypoglycemia in Individuals With Type 1 Diabetes on Continuous Subcutaneous

تفاصيل العنوان

Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6).

• Authors : Boye, Kristina Secnik^1,2 ; Poon, Jiat Ling¹; Landó, Laura Fernández¹

• Source: Diabetes Therapy. Sep2024, Vol. 15 Issue 9, p2039-2059. 21p.

تفاصيل العنوان

A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)

• Source: A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three

تفاصيل العنوان

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes

• Source: A Phase 3, Randomized, Open-Label, Multicenter, Active-controlled Trial Comparing Efficacy and Safety of THDB0206 Injection With Insulin

تفاصيل العنوان

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

• Source: A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With

تفاصيل العنوان

A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes

• Source: A Randomized, Double-blind, Single-dose, 2-treatment, 2-period, 2-sequence Crossover Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin

تفاصيل العنوان

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

• Source: A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With

تفاصيل العنوان

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes (PRONTO-Peds)

• Source: A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes

تفاصيل العنوان